Related Experiment Video
Updated: Dec 23, 2025

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.3K
Long-term evaluation of climatotherapy for psoriasis
Hannah Trøstrup1, Peter Theut Riis1, Michael Heidenheim1
1Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
Dermatologic Therapy
|April 22, 2020
Summary
Climatotherapy (CT) offers significant short-term psoriasis relief. Long-term follow-up shows sustained improvements in Psoriasis Area Severity Index (PASI) and Dermatology Life Quality Index (DLQI) for many patients.
Area of Science:
- Dermatology
- Therapeutics
- Public Health
Background:
- Climatotherapy (CT) is recognized for its rapid clearance rates in chronic psoriasis.
- However, limited data exists regarding the long-term efficacy and impact of CT on patient quality of life.
- This study investigates the sustained effects of a single CT treatment course.
Purpose of the Study:
- To assess the long-term impact of a 4-week Climatotherapy (CT) treatment on psoriasis disease activity and quality of life.
- To evaluate outcomes at 4- to 6-month follow-ups after CT completion.
- To determine factors influencing treatment success and patient-reported outcomes.
Main Methods:
- A prospective study involving 49 patients with psoriasis undergoing 4 weeks of CT in Israel.
- Psoriasis Area Severity Index (PASI) and Dermatology Life Quality Index (DLQI) scores were recorded before CT and at a mean 5-month follow-up.
- Statistical analysis was performed to compare pre- and post-treatment scores and identify significant changes.
Main Results:
- A mean PASI reduction of 3.2 (39.5%) was observed, with 11 out of 49 patients achieving PASI 75.
- The mean DLQI score significantly decreased from 16.1 to 10.6, with 33 patients reaching a minimal clinically important difference.
- Six out of ten patients reported a clinically important improvement in quality of life.
Conclusions:
- A single course of Climatotherapy (CT) provides significant and clinically meaningful long-term benefits for psoriasis patients.
- Sustained improvements in both disease severity (PASI) and quality of life (DLQI) are achievable 4-6 months post-treatment.
- CT represents a valuable therapeutic option for managing chronic psoriasis, offering lasting relief beyond the treatment period.

